89891-70-3 Usage
Uses
Used in Pharmaceutical Industry:
3-Bromo-4-cyanobenzaldehyde is used as a key intermediate in the synthesis of various pharmaceuticals for its unique reactivity and ability to form complex molecular structures. Its presence in the synthesis process can contribute to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, 3-Bromo-4-cyanobenzaldehyde serves as an essential intermediate in the production of agrochemicals, such as pesticides and herbicides. Its unique chemical structure allows for the creation of compounds with targeted effects on pests or weeds, enhancing the efficiency and selectivity of these products.
Used in Organic Synthesis:
3-Bromo-4-cyanobenzaldehyde is used as a building block in organic synthesis for the preparation of complex organic molecules. Its distinct chemical properties make it a versatile reagent in the creation of a wide range of organic compounds, contributing to advancements in various fields of chemistry.
Used in Research and Development:
3-Bromo-4-cyanobenzaldehyde is also utilized in research and development settings, where its unique reactivity and structural features are explored for potential applications in new chemical reactions and the discovery of novel compounds with specific properties. Its use in research helps to expand the understanding of organic chemistry and drive innovation in the field.
Check Digit Verification of cas no
The CAS Registry Mumber 89891-70-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,8,9 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 89891-70:
(7*8)+(6*9)+(5*8)+(4*9)+(3*1)+(2*7)+(1*0)=203
203 % 10 = 3
So 89891-70-3 is a valid CAS Registry Number.
89891-70-3Relevant academic research and scientific papers
ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4)(BETA7)
-
Paragraph 0228; 0559; 0560, (2019/10/29)
Disclosed are small molecule antagonists of α4β7 integrin, and methods of using them to treat a number of specific diseases or conditions.
Design and synthesis of o-trifluoromethylbiphenyl substituted 2-amino-nicotinonitriles as inhibitors of farnesyltransferase
Wang, Gary T.,Wang, Xilu,Wang, Weibo,Hasvold, Lisa A.,Sullivan, Gerry,Hutchins, Charles W.,O'Conner, Steve,Gentiles, Robert,Sowin, Thomas,Cohen, Jerry,Gu, Wen-Zhen,Zhang, Haiying,Rosenberg, Saul H.,Sham, Hing L.
, p. 153 - 158 (2007/10/03)
A non-methionine FT inhibitor lead structure (1) was designed through computer modeling of the peptidomimetic FT inhibitor ABT839. Optimization of this lead resulted in compounds 2e and 2g, with FT IC50 values of 1.3 and 1.8 nM, GGT IC50 of 1400 nM, and EC50 (Ras processing) values of 13 and 11 nM, respectively.
Substituted phenyl farnesyltransferase inhibitors
-
, (2012/09/25)
Compounds of formula (I) or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
